Duke Rohlen Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Duke Rohlen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Duke Rohlen. Duke Rohlen is President Strategic Operations in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and President, Molecular Programs in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and Director in ENTELLUS MEDICAL INC ($ENTL) and Director in Eidos Therapeutics, Inc. ($EIDX).
Latest Insider Trading Transactions of Duke Rohlen
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EIDX, ENTL, FOXH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | D | 0.00 | 4,526 | 0 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | D | 41.42 | 21,447 | 888,335 | 0 | |
Aug 10 2020 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | A | 41.42 | 21,447 | 888,335 | 21,447 | |
Aug 10 2020 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | A | 0.00 | 4,526 | 0 | 4,526 | |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Option Exercise | D | 17.67 | 7,500 | 132,525 | 0 | |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Option Exercise | D | 17.67 | 7,500 | 132,525 | 0 | |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 4,684 | 112,416 | 0 | 4.7 K to 0 (-100.00 %) |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 4,684 | 112,416 | 0 | 4.7 K to 0 (-100.00 %) |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 20,299 | 487,176 | 0 | 20.3 K to 0 (-100.00 %) |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 20,299 | 487,176 | 0 | 20.3 K to 0 (-100.00 %) |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 6,834 | 164,016 | 0 | 6.8 K to 0 (-100.00 %) |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 6,834 | 164,016 | 0 | 6.8 K to 0 (-100.00 %) |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 9,217 | 221,208 | 0 | 9.2 K to 0 (-100.00 %) |
Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 9,217 | 221,208 | 0 | 9.2 K to 0 (-100.00 %) |
Jul 18 2017 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Option Exercise | A | 17.67 | 7,500 | 132,525 | 7,500 | |
Jul 18 2017 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Grant | A | 0.00 | 3,750 | 0 | 9,217 | 5.5 K to 9.2 K (+68.59 %) |
Feb 22 2006 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President Strategic ... | Option Exercise | A | 30.60 | 50,000 | 1,530,000 | 50,000 | |
Feb 02 2006 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President Strategic ... | Sell | S | 26.35 | 7,500 | 197,625 | 406,757 | 414.3 K to 406.8 K (-1.81 %) |
Jan 05 2006 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 30.31 | 7,500 | 227,293 | 414,257 | 421.8 K to 414.3 K (-1.78 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 46.67 | 3,000 | 140,010 | 429,257 | 432.3 K to 429.3 K (-0.69 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 46.01 | 1,000 | 46,010 | 432,257 | 433.3 K to 432.3 K (-0.23 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 45.94 | 1,000 | 45,940 | 433,257 | 434.3 K to 433.3 K (-0.23 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 45.85 | 2,500 | 114,625 | 434,257 | 436.8 K to 434.3 K (-0.57 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 46.77 | 7,500 | 350,775 | 436,757 | 444.3 K to 436.8 K (-1.69 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 43.52 | 2,500 | 108,800 | 421,757 | 424.3 K to 421.8 K (-0.59 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 43.53 | 1,000 | 43,530 | 424,257 | 425.3 K to 424.3 K (-0.24 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 43.55 | 1,500 | 65,325 | 425,257 | 426.8 K to 425.3 K (-0.35 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 43.59 | 1,500 | 65,385 | 426,757 | 428.3 K to 426.8 K (-0.35 %) |
Dec 05 2005 | FOXH | FOXHOLLOW TECHNOLO ... | Rohlen Duke | President, Molecula ... | Sell | S | 43.62 | 1,000 | 43,620 | 428,257 | 429.3 K to 428.3 K (-0.23 %) |
Page: 1